glp-1 ckd Glucagon-like Peptide Receptor Agonists and Kidney Outcomes in the Era of Personalized Medicine: Focus on Albuminuria glp1 #gip #semaglutide #tirzepatide #liraglutide
Description
During the call, they reviewed the medical history that I provided, current medications, and asked whether I had any questions or concerns
About the Author Lindsay Warner, Content Licensing Editor, Harvard Health Publishing About the Reviewer Teresa Fung, ScD, RD, Contributor
The researchers found that GLP-1 receptor agonist initiation was associated with a reduced risk for disorders related to alcohol use, cannabis use, cocaine use, nicotine use, opioid use, and other SUDs compared with initiation of SGLT-2 inhibitors (hazard ratios, 0.82, 0.86, 0.80, 0.80, 0.75, and 0.87, respectively) and with a reduced risk for the composite outcome of all incident SUDs (hazard ratio, 0.86)
309020074 More Information More Information Manufacturer GLP Small New Products Martin Mac Quantum - Yoke Shell 23404510 68.00 excl
in: PubMed | Google Scholar 1 Department of Internal Medicine-Molecular Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA
Understanding prescriber qualifications is essential when you buy GLP-1 medications online to ensure you receive safe and legitimate treatment
